A Study of Single and Repeat Dose Administration of UBX0101 in Patients With Osteoarthritis of the Knee
Clinical trial NCT04229225 · COMPLETED
Trial details
- NCT number
- NCT04229225
- Sponsor
- Unity Biotechnology, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-23
- Primary completion
- 2020-09-18
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.